QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAnna Evans Phillips
About this trial
Quantitative Sensory Testing (QST) is a novel investigative technique used in other pain conditions to evaluate patterns of chronic pain, and in this study will be used to elucidate pain patterns in patients with Chronic Pancreatitis (CP). QST uses a specific series of standardized stimulations to map the pain system. QST has the potential to change and improve the treatment paradigm for patients with CP and may eventually be able to predict response to invasive CP therapies.
Eligibility criteria
Qualifiers
Subjects with no pancreatic disease and no abdominal pain, or patients with a diagnosis of functional dyspepsia.
Subjects are 18 years or older in age
Subjects must be able to read and understand the study information.
Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study.
Disqualifiers
Subjects with no pancreatic disease and no abdominal pain, or patients with a diagnosis of functional dyspepsia.
Subjects with evidence or history of medical or surgical disease of importance for this study as judged by investigator.
Subjects suffering from painful conditions that make them unable to distinguish the pain associated with CP from chronic pain of other origins.
Subjects with known pregnancy at the time of enrolment.
Trial design
Treatments tested in this trial
- Quantitative Sensory Test 1
- Quantitative Sensory Test 2
- Quantitative Sensory Test 3
Treatment groups
500 Participants
are divided into 4 treatment groupsSponsors and collaborators
Anna Evans Phillips
Lead sponsor
University of Pittsburgh
Sponsor institution
Johns Hopkins University
Collaborator
Aalborg University
Collaborator
Source ClinicalTrials.gov